Auvynet,C. El-Amri,C. Lacombe,C. Bruston,F. Bourdais,J. Nicolas,P. Rosenstein,Y.
2008. Structural requirements for antimicrobial versus chemoattractant activities for dermaseptin S9 Febs Journal, 275, 4134-4151.
Chavez-Gutierrez,L. Bourdais,J. Aranda,G. Vargas,M.A. Matta-Camacho,E. Ducancel,F. Segovia,L. Joseph-Bravo,P. Charli,J.L.
2005. A truncated isoform of pyroglutamyl aminopeptidase II produced by exon extension has dominant-negative activity Journal of Neurochemistry, 92, 807-817.
Bourdais,J. Romero,F. Uriostegui,B. Cisneros,M. Joseph-Bravo,P. Charli,J.L.
2000. [3-Me-His(2)]-TRH combined with dopamine withdrawal rapidly and transiently increases pyroglutamyl aminopeptidase II activity in primary cultures of adenohypophyseal cells Neuropeptides, 34, 83-88.
Vargas,M.A. Bourdais,J. Sanchez,S. Uriostegui,B. Moreno,E. Joseph-Bravo,P. Charli,J.L.
1998. Multiple hypothalamic factors regulate pyroglutamyl peptidase II in cultures of adenohypophyseal cells: role of the cAMP pathway Journal of Neuroendocrinology, 10, 199-206.
Charli,J.L. Vargas,M.A. Cisneros,M. de Gortari,P. Baeza,M.A. Jasso,P. Bourdais,J. Perez,L. Uribe,R.M. Joseph-Bravo,P.
1998. TRH inactivation in the extracellular compartment: role of pyroglutamyl peptidase II.Neurobiology (Bp.), 6, 45-57.
ex-colaborador y/o ex-alumno